Gene Therapy Supply Chain & CDMO Market Size Forecast Share Trends Industry Analysis 2025–2032
The Gene Therapy Supply Chain & CDMO Market was valued at US$ 4,987.34 Million in 2024 and is projected to expand at a CAGR of 12.3% from 2025 to 2032. The market is supported by increasing gene therapy development activities, rising outsourcing of specialized manufacturing to contract development and manufacturing organizations (CDMOs), growing regulatory emphasis on quality and...
0 Comments 0 Shares 11 Views 0 Reviews
Abistem https://abistem.com